nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxymorphone—Naloxone—TLR4—Crohn's disease	0.0499	0.889	CrCbGaD
Oxymorphone—Lung disorder—Mesalazine—Crohn's disease	0.0169	0.0262	CcSEcCtD
Oxymorphone—Dermatitis atopic—Mesalazine—Crohn's disease	0.0161	0.0251	CcSEcCtD
Oxymorphone—Withdrawal syndrome—Prednisone—Crohn's disease	0.0151	0.0235	CcSEcCtD
Oxymorphone—Intracranial pressure increased—Prednisone—Crohn's disease	0.0151	0.0235	CcSEcCtD
Oxymorphone—Immune system disorder—Mercaptopurine—Crohn's disease	0.00998	0.0155	CcSEcCtD
Oxymorphone—Disorientation—Mesalazine—Crohn's disease	0.00969	0.0151	CcSEcCtD
Oxymorphone—Malnutrition—Mercaptopurine—Crohn's disease	0.00962	0.015	CcSEcCtD
Oxymorphone—Lethargy—Mesalazine—Crohn's disease	0.00885	0.0138	CcSEcCtD
Oxymorphone—Dermatitis atopic—Prednisone—Crohn's disease	0.00854	0.0133	CcSEcCtD
Oxymorphone—OPRD1—Peptide GPCRs—CCR9—Crohn's disease	0.00831	0.0277	CbGpPWpGaD
Oxymorphone—Unspecified disorder of skin and subcutaneous tissue—Mercaptopurine—Crohn's disease	0.00814	0.0126	CcSEcCtD
Oxymorphone—Memory impairment—Prednisone—Crohn's disease	0.00805	0.0125	CcSEcCtD
Oxymorphone—Orthostatic hypotension—Mesalazine—Crohn's disease	0.00792	0.0123	CcSEcCtD
Oxymorphone—Oedema—Mercaptopurine—Crohn's disease	0.00785	0.0122	CcSEcCtD
Oxymorphone—Skin disorder—Mercaptopurine—Crohn's disease	0.00763	0.0119	CcSEcCtD
Oxymorphone—Abdominal distension—Mesalazine—Crohn's disease	0.00755	0.0117	CcSEcCtD
Oxymorphone—Anorexia—Mercaptopurine—Crohn's disease	0.00749	0.0116	CcSEcCtD
Oxymorphone—Pneumonia—Azathioprine—Crohn's disease	0.00738	0.0115	CcSEcCtD
Oxymorphone—Bronchospasm—Mesalazine—Crohn's disease	0.00737	0.0115	CcSEcCtD
Oxymorphone—OPRK1—Peptide GPCRs—CCR9—Crohn's disease	0.00728	0.0243	CbGpPWpGaD
Oxymorphone—Decreased appetite—Mercaptopurine—Crohn's disease	0.00683	0.0106	CcSEcCtD
Oxymorphone—Weight decreased—Mesalazine—Crohn's disease	0.00678	0.0105	CcSEcCtD
Oxymorphone—Gastrointestinal disorder—Mercaptopurine—Crohn's disease	0.00678	0.0105	CcSEcCtD
Oxymorphone—Pneumonia—Mesalazine—Crohn's disease	0.00672	0.0104	CcSEcCtD
Oxymorphone—Naloxone—ALB—Crohn's disease	0.00623	0.111	CrCbGaD
Oxymorphone—Body temperature increased—Mercaptopurine—Crohn's disease	0.00621	0.00965	CcSEcCtD
Oxymorphone—OPRM1—Peptide GPCRs—CCR9—Crohn's disease	0.00616	0.0205	CbGpPWpGaD
Oxymorphone—Immune system disorder—Azathioprine—Crohn's disease	0.00595	0.00924	CcSEcCtD
Oxymorphone—OPRD1—Peptide ligand-binding receptors—ACKR2—Crohn's disease	0.00595	0.0198	CbGpPWpGaD
Oxymorphone—Mediastinal disorder—Azathioprine—Crohn's disease	0.00594	0.00922	CcSEcCtD
Oxymorphone—Urinary tract disorder—Mesalazine—Crohn's disease	0.00592	0.00921	CcSEcCtD
Oxymorphone—Urethral disorder—Mesalazine—Crohn's disease	0.00588	0.00914	CcSEcCtD
Oxymorphone—Hypersensitivity—Mercaptopurine—Crohn's disease	0.00579	0.00899	CcSEcCtD
Oxymorphone—OPRD1—Peptide ligand-binding receptors—MLN—Crohn's disease	0.00564	0.0188	CbGpPWpGaD
Oxymorphone—Eye disorder—Mesalazine—Crohn's disease	0.00561	0.00871	CcSEcCtD
Oxymorphone—Cardiac disorder—Mesalazine—Crohn's disease	0.00557	0.00865	CcSEcCtD
Oxymorphone—OPRD1—Peptide GPCRs—CCR6—Crohn's disease	0.0055	0.0183	CbGpPWpGaD
Oxymorphone—Angiopathy—Mesalazine—Crohn's disease	0.00544	0.00846	CcSEcCtD
Oxymorphone—Euphoric mood—Prednisone—Crohn's disease	0.00543	0.00844	CcSEcCtD
Oxymorphone—Immune system disorder—Mesalazine—Crohn's disease	0.00542	0.00842	CcSEcCtD
Oxymorphone—Mediastinal disorder—Mesalazine—Crohn's disease	0.00541	0.0084	CcSEcCtD
Oxymorphone—Diarrhoea—Mercaptopurine—Crohn's disease	0.00537	0.00835	CcSEcCtD
Oxymorphone—Mental disorder—Mesalazine—Crohn's disease	0.00526	0.00817	CcSEcCtD
Oxymorphone—OPRK1—Peptide ligand-binding receptors—ACKR2—Crohn's disease	0.00521	0.0174	CbGpPWpGaD
Oxymorphone—Flatulence—Mesalazine—Crohn's disease	0.00515	0.008	CcSEcCtD
Oxymorphone—Tension—Mesalazine—Crohn's disease	0.00512	0.00796	CcSEcCtD
Oxymorphone—Nervousness—Mesalazine—Crohn's disease	0.00507	0.00788	CcSEcCtD
Oxymorphone—Vomiting—Mercaptopurine—Crohn's disease	0.00499	0.00776	CcSEcCtD
Oxymorphone—Dermatitis—Mercaptopurine—Crohn's disease	0.00495	0.00769	CcSEcCtD
Oxymorphone—OPRK1—Peptide ligand-binding receptors—MLN—Crohn's disease	0.00494	0.0165	CbGpPWpGaD
Oxymorphone—Vision blurred—Mesalazine—Crohn's disease	0.00492	0.00765	CcSEcCtD
Oxymorphone—Amnesia—Prednisone—Crohn's disease	0.00488	0.00759	CcSEcCtD
Oxymorphone—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—Crohn's disease	0.00485	0.00753	CcSEcCtD
Oxymorphone—OPRK1—Peptide GPCRs—CCR6—Crohn's disease	0.00483	0.0161	CbGpPWpGaD
Oxymorphone—Vertigo—Mesalazine—Crohn's disease	0.00469	0.00729	CcSEcCtD
Oxymorphone—Syncope—Mesalazine—Crohn's disease	0.00468	0.00728	CcSEcCtD
Oxymorphone—Lethargy—Prednisone—Crohn's disease	0.00468	0.00727	CcSEcCtD
Oxymorphone—Nausea—Mercaptopurine—Crohn's disease	0.00466	0.00725	CcSEcCtD
Oxymorphone—OPRD1—GPCRs, Class A Rhodopsin-like—ACKR2—Crohn's disease	0.00466	0.0155	CbGpPWpGaD
Oxymorphone—Palpitations—Mesalazine—Crohn's disease	0.00461	0.00717	CcSEcCtD
Oxymorphone—Loss of consciousness—Mesalazine—Crohn's disease	0.00459	0.00713	CcSEcCtD
Oxymorphone—Skin disorder—Azathioprine—Crohn's disease	0.00454	0.00706	CcSEcCtD
Oxymorphone—Hypertension—Mesalazine—Crohn's disease	0.00451	0.00701	CcSEcCtD
Oxymorphone—Chest pain—Mesalazine—Crohn's disease	0.00445	0.00691	CcSEcCtD
Oxymorphone—Anxiety—Mesalazine—Crohn's disease	0.00443	0.00688	CcSEcCtD
Oxymorphone—Unspecified disorder of skin and subcutaneous tissue—Mesalazine—Crohn's disease	0.00442	0.00686	CcSEcCtD
Oxymorphone—OPRM1—Peptide ligand-binding receptors—ACKR2—Crohn's disease	0.00441	0.0147	CbGpPWpGaD
Oxymorphone—Hypotension—Azathioprine—Crohn's disease	0.00437	0.00679	CcSEcCtD
Oxymorphone—Dry mouth—Mesalazine—Crohn's disease	0.00435	0.00676	CcSEcCtD
Oxymorphone—Confusional state—Mesalazine—Crohn's disease	0.0043	0.00668	CcSEcCtD
Oxymorphone—Oedema—Mesalazine—Crohn's disease	0.00426	0.00662	CcSEcCtD
Oxymorphone—Shock—Mesalazine—Crohn's disease	0.00419	0.00652	CcSEcCtD
Oxymorphone—Nervous system disorder—Mesalazine—Crohn's disease	0.00418	0.00649	CcSEcCtD
Oxymorphone—OPRM1—Peptide ligand-binding receptors—MLN—Crohn's disease	0.00418	0.0139	CbGpPWpGaD
Oxymorphone—Tachycardia—Mesalazine—Crohn's disease	0.00416	0.00646	CcSEcCtD
Oxymorphone—Skin disorder—Mesalazine—Crohn's disease	0.00414	0.00643	CcSEcCtD
Oxymorphone—Hyperhidrosis—Mesalazine—Crohn's disease	0.00412	0.0064	CcSEcCtD
Oxymorphone—OPRK1—GPCRs, Class A Rhodopsin-like—ACKR2—Crohn's disease	0.00408	0.0136	CbGpPWpGaD
Oxymorphone—OPRM1—Peptide GPCRs—CCR6—Crohn's disease	0.00408	0.0136	CbGpPWpGaD
Oxymorphone—Anorexia—Mesalazine—Crohn's disease	0.00406	0.00631	CcSEcCtD
Oxymorphone—Gastrointestinal disorder—Azathioprine—Crohn's disease	0.00404	0.00628	CcSEcCtD
Oxymorphone—Abdominal distension—Prednisone—Crohn's disease	0.00399	0.0062	CcSEcCtD
Oxymorphone—OPRD1—Class A/1 (Rhodopsin-like receptors)—ACKR2—Crohn's disease	0.00399	0.0133	CbGpPWpGaD
Oxymorphone—Hypotension—Mesalazine—Crohn's disease	0.00398	0.00619	CcSEcCtD
Oxymorphone—OPRD1—Peptide ligand-binding receptors—CCR9—Crohn's disease	0.00391	0.013	CbGpPWpGaD
Oxymorphone—Sweating increased—Prednisone—Crohn's disease	0.00386	0.006	CcSEcCtD
Oxymorphone—Feeling abnormal—Azathioprine—Crohn's disease	0.00386	0.00599	CcSEcCtD
Oxymorphone—Insomnia—Mesalazine—Crohn's disease	0.00385	0.00599	CcSEcCtD
Oxymorphone—Gastrointestinal pain—Azathioprine—Crohn's disease	0.00383	0.00595	CcSEcCtD
Oxymorphone—Dyspnoea—Mesalazine—Crohn's disease	0.0038	0.0059	CcSEcCtD
Oxymorphone—Somnolence—Mesalazine—Crohn's disease	0.00379	0.00589	CcSEcCtD
Oxymorphone—OPRD1—Class A/1 (Rhodopsin-like receptors)—MLN—Crohn's disease	0.00378	0.0126	CbGpPWpGaD
Oxymorphone—Dyspepsia—Mesalazine—Crohn's disease	0.00375	0.00583	CcSEcCtD
Oxymorphone—Decreased appetite—Mesalazine—Crohn's disease	0.0037	0.00576	CcSEcCtD
Oxymorphone—Abdominal pain—Azathioprine—Crohn's disease	0.0037	0.00575	CcSEcCtD
Oxymorphone—Body temperature increased—Azathioprine—Crohn's disease	0.0037	0.00575	CcSEcCtD
Oxymorphone—Gastrointestinal disorder—Mesalazine—Crohn's disease	0.00368	0.00572	CcSEcCtD
Oxymorphone—Fatigue—Mesalazine—Crohn's disease	0.00367	0.00571	CcSEcCtD
Oxymorphone—Constipation—Mesalazine—Crohn's disease	0.00364	0.00566	CcSEcCtD
Oxymorphone—Pain—Mesalazine—Crohn's disease	0.00364	0.00566	CcSEcCtD
Oxymorphone—Weight decreased—Prednisone—Crohn's disease	0.00359	0.00557	CcSEcCtD
Oxymorphone—Feeling abnormal—Mesalazine—Crohn's disease	0.00351	0.00546	CcSEcCtD
Oxymorphone—OPRK1—Class A/1 (Rhodopsin-like receptors)—ACKR2—Crohn's disease	0.0035	0.0116	CbGpPWpGaD
Oxymorphone—Gastrointestinal pain—Mesalazine—Crohn's disease	0.00349	0.00542	CcSEcCtD
Oxymorphone—OPRM1—GPCRs, Class A Rhodopsin-like—ACKR2—Crohn's disease	0.00345	0.0115	CbGpPWpGaD
Oxymorphone—Hypersensitivity—Azathioprine—Crohn's disease	0.00345	0.00536	CcSEcCtD
Oxymorphone—OPRK1—Peptide ligand-binding receptors—CCR9—Crohn's disease	0.00343	0.0114	CbGpPWpGaD
Oxymorphone—Urticaria—Mesalazine—Crohn's disease	0.00339	0.00526	CcSEcCtD
Oxymorphone—Abdominal pain—Mesalazine—Crohn's disease	0.00337	0.00524	CcSEcCtD
Oxymorphone—Body temperature increased—Mesalazine—Crohn's disease	0.00337	0.00524	CcSEcCtD
Oxymorphone—OPRK1—Class A/1 (Rhodopsin-like receptors)—MLN—Crohn's disease	0.00332	0.011	CbGpPWpGaD
Oxymorphone—OPRD1—G alpha (i) signalling events—CCR9—Crohn's disease	0.0033	0.011	CbGpPWpGaD
Oxymorphone—Bradycardia—Prednisone—Crohn's disease	0.00323	0.00502	CcSEcCtD
Oxymorphone—Diarrhoea—Azathioprine—Crohn's disease	0.0032	0.00497	CcSEcCtD
Oxymorphone—Hallucination—Prednisone—Crohn's disease	0.00316	0.00491	CcSEcCtD
Oxymorphone—Hypersensitivity—Mesalazine—Crohn's disease	0.00314	0.00488	CcSEcCtD
Oxymorphone—Dizziness—Azathioprine—Crohn's disease	0.00309	0.00481	CcSEcCtD
Oxymorphone—OPRM1—IL4-mediated signaling events—SOCS1—Crohn's disease	0.00309	0.0103	CbGpPWpGaD
Oxymorphone—OPRD1—GPCRs, Class A Rhodopsin-like—CCR9—Crohn's disease	0.00306	0.0102	CbGpPWpGaD
Oxymorphone—Asthenia—Mesalazine—Crohn's disease	0.00306	0.00475	CcSEcCtD
Oxymorphone—OPRD1—GPCR ligand binding—ACKR2—Crohn's disease	0.00304	0.0101	CbGpPWpGaD
Oxymorphone—OPRM1—TCR Signaling Pathway—IL17A—Crohn's disease	0.00302	0.0101	CbGpPWpGaD
Oxymorphone—Pruritus—Mesalazine—Crohn's disease	0.00302	0.00469	CcSEcCtD
Oxymorphone—Vomiting—Azathioprine—Crohn's disease	0.00297	0.00462	CcSEcCtD
Oxymorphone—Eye disorder—Prednisone—Crohn's disease	0.00297	0.00461	CcSEcCtD
Oxymorphone—OPRM1—Class A/1 (Rhodopsin-like receptors)—ACKR2—Crohn's disease	0.00296	0.00984	CbGpPWpGaD
Oxymorphone—Dermatitis—Azathioprine—Crohn's disease	0.00295	0.00458	CcSEcCtD
Oxymorphone—Flushing—Prednisone—Crohn's disease	0.00295	0.00458	CcSEcCtD
Oxymorphone—Headache—Azathioprine—Crohn's disease	0.00293	0.00455	CcSEcCtD
Oxymorphone—Diarrhoea—Mesalazine—Crohn's disease	0.00292	0.00453	CcSEcCtD
Oxymorphone—OPRM1—Peptide ligand-binding receptors—CCR9—Crohn's disease	0.0029	0.00964	CbGpPWpGaD
Oxymorphone—OPRK1—G alpha (i) signalling events—CCR9—Crohn's disease	0.00289	0.00963	CbGpPWpGaD
Oxymorphone—Angiopathy—Prednisone—Crohn's disease	0.00288	0.00447	CcSEcCtD
Oxymorphone—OPRD1—GPCR ligand binding—MLN—Crohn's disease	0.00288	0.00959	CbGpPWpGaD
Oxymorphone—Immune system disorder—Prednisone—Crohn's disease	0.00287	0.00445	CcSEcCtD
Oxymorphone—OPRD1—GPCRs, Class A Rhodopsin-like—GPR65—Crohn's disease	0.00284	0.00947	CbGpPWpGaD
Oxymorphone—Dizziness—Mesalazine—Crohn's disease	0.00282	0.00438	CcSEcCtD
Oxymorphone—OPRM1—Class A/1 (Rhodopsin-like receptors)—MLN—Crohn's disease	0.0028	0.00933	CbGpPWpGaD
Oxymorphone—Mental disorder—Prednisone—Crohn's disease	0.00278	0.00432	CcSEcCtD
Oxymorphone—Nausea—Azathioprine—Crohn's disease	0.00278	0.00432	CcSEcCtD
Oxymorphone—OPRM1—IL4-mediated signaling events—IL10—Crohn's disease	0.00277	0.00922	CbGpPWpGaD
Oxymorphone—Malnutrition—Prednisone—Crohn's disease	0.00276	0.00429	CcSEcCtD
Oxymorphone—Vomiting—Mesalazine—Crohn's disease	0.00271	0.00421	CcSEcCtD
Oxymorphone—Dermatitis—Mesalazine—Crohn's disease	0.00268	0.00417	CcSEcCtD
Oxymorphone—OPRK1—GPCRs, Class A Rhodopsin-like—CCR9—Crohn's disease	0.00268	0.00893	CbGpPWpGaD
Oxymorphone—OPRM1—TCR Signaling Pathway—RIPK2—Crohn's disease	0.00268	0.00893	CbGpPWpGaD
Oxymorphone—Headache—Mesalazine—Crohn's disease	0.00267	0.00415	CcSEcCtD
Oxymorphone—OPRK1—GPCR ligand binding—ACKR2—Crohn's disease	0.00266	0.00887	CbGpPWpGaD
Oxymorphone—OPRD1—Class A/1 (Rhodopsin-like receptors)—CCR9—Crohn's disease	0.00262	0.00873	CbGpPWpGaD
Oxymorphone—Vision blurred—Prednisone—Crohn's disease	0.0026	0.00405	CcSEcCtD
Oxymorphone—OPRD1—Peptide ligand-binding receptors—CCR6—Crohn's disease	0.00259	0.00862	CbGpPWpGaD
Oxymorphone—Agitation—Prednisone—Crohn's disease	0.00254	0.00395	CcSEcCtD
Oxymorphone—Nausea—Mesalazine—Crohn's disease	0.00253	0.00393	CcSEcCtD
Oxymorphone—OPRK1—GPCR ligand binding—MLN—Crohn's disease	0.00252	0.00841	CbGpPWpGaD
Oxymorphone—OPRK1—GPCRs, Class A Rhodopsin-like—GPR65—Crohn's disease	0.00249	0.0083	CbGpPWpGaD
Oxymorphone—Vertigo—Prednisone—Crohn's disease	0.00248	0.00386	CcSEcCtD
Oxymorphone—Syncope—Prednisone—Crohn's disease	0.00248	0.00385	CcSEcCtD
Oxymorphone—OPRM1—G alpha (i) signalling events—CCR9—Crohn's disease	0.00244	0.00814	CbGpPWpGaD
Oxymorphone—OPRD1—Class A/1 (Rhodopsin-like receptors)—GPR65—Crohn's disease	0.00244	0.00811	CbGpPWpGaD
Oxymorphone—Loss of consciousness—Prednisone—Crohn's disease	0.00243	0.00377	CcSEcCtD
Oxymorphone—Convulsion—Prednisone—Crohn's disease	0.00239	0.00372	CcSEcCtD
Oxymorphone—Hypertension—Prednisone—Crohn's disease	0.00239	0.00371	CcSEcCtD
Oxymorphone—Anxiety—Prednisone—Crohn's disease	0.00234	0.00364	CcSEcCtD
Oxymorphone—Unspecified disorder of skin and subcutaneous tissue—Prednisone—Crohn's disease	0.00234	0.00363	CcSEcCtD
Oxymorphone—OPRK1—Class A/1 (Rhodopsin-like receptors)—CCR9—Crohn's disease	0.0023	0.00765	CbGpPWpGaD
Oxymorphone—OPRK1—Peptide ligand-binding receptors—CCR6—Crohn's disease	0.00227	0.00756	CbGpPWpGaD
Oxymorphone—OPRM1—GPCRs, Class A Rhodopsin-like—CCR9—Crohn's disease	0.00227	0.00755	CbGpPWpGaD
Oxymorphone—Oedema—Prednisone—Crohn's disease	0.00225	0.0035	CcSEcCtD
Oxymorphone—OPRM1—GPCR ligand binding—ACKR2—Crohn's disease	0.00225	0.0075	CbGpPWpGaD
Oxymorphone—Shock—Prednisone—Crohn's disease	0.00222	0.00345	CcSEcCtD
Oxymorphone—Nervous system disorder—Prednisone—Crohn's disease	0.00221	0.00344	CcSEcCtD
Oxymorphone—Tachycardia—Prednisone—Crohn's disease	0.0022	0.00342	CcSEcCtD
Oxymorphone—Skin disorder—Prednisone—Crohn's disease	0.00219	0.0034	CcSEcCtD
Oxymorphone—OPRD1—G alpha (i) signalling events—CCR6—Crohn's disease	0.00218	0.00727	CbGpPWpGaD
Oxymorphone—Hyperhidrosis—Prednisone—Crohn's disease	0.00218	0.00339	CcSEcCtD
Oxymorphone—Anorexia—Prednisone—Crohn's disease	0.00215	0.00334	CcSEcCtD
Oxymorphone—OPRK1—Class A/1 (Rhodopsin-like receptors)—GPR65—Crohn's disease	0.00214	0.00712	CbGpPWpGaD
Oxymorphone—OPRM1—GPCR ligand binding—MLN—Crohn's disease	0.00213	0.00711	CbGpPWpGaD
Oxymorphone—OPRM1—GPCRs, Class A Rhodopsin-like—GPR65—Crohn's disease	0.00211	0.00702	CbGpPWpGaD
Oxymorphone—Insomnia—Prednisone—Crohn's disease	0.00204	0.00317	CcSEcCtD
Oxymorphone—OPRD1—GPCRs, Class A Rhodopsin-like—CCR6—Crohn's disease	0.00203	0.00675	CbGpPWpGaD
Oxymorphone—OPRD1—GPCR ligand binding—CCR9—Crohn's disease	0.002	0.00665	CbGpPWpGaD
Oxymorphone—Dyspepsia—Prednisone—Crohn's disease	0.00198	0.00308	CcSEcCtD
Oxymorphone—Decreased appetite—Prednisone—Crohn's disease	0.00196	0.00305	CcSEcCtD
Oxymorphone—Fatigue—Prednisone—Crohn's disease	0.00194	0.00302	CcSEcCtD
Oxymorphone—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCR9—Crohn's disease	0.00194	0.00647	CbGpPWpGaD
Oxymorphone—Constipation—Prednisone—Crohn's disease	0.00193	0.003	CcSEcCtD
Oxymorphone—OPRM1—Peptide ligand-binding receptors—CCR6—Crohn's disease	0.00192	0.00639	CbGpPWpGaD
Oxymorphone—OPRK1—G alpha (i) signalling events—CCR6—Crohn's disease	0.00191	0.00638	CbGpPWpGaD
Oxymorphone—Feeling abnormal—Prednisone—Crohn's disease	0.00186	0.00289	CcSEcCtD
Oxymorphone—OPRD1—GPCR ligand binding—GPR65—Crohn's disease	0.00186	0.00618	CbGpPWpGaD
Oxymorphone—Gastrointestinal pain—Prednisone—Crohn's disease	0.00184	0.00287	CcSEcCtD
Oxymorphone—OPRM1—Class A/1 (Rhodopsin-like receptors)—GPR65—Crohn's disease	0.00181	0.00601	CbGpPWpGaD
Oxymorphone—Urticaria—Prednisone—Crohn's disease	0.00179	0.00278	CcSEcCtD
Oxymorphone—OPRD1—GPCRs, Class A Rhodopsin-like—PTGER4—Crohn's disease	0.00178	0.00594	CbGpPWpGaD
Oxymorphone—Body temperature increased—Prednisone—Crohn's disease	0.00178	0.00277	CcSEcCtD
Oxymorphone—Abdominal pain—Prednisone—Crohn's disease	0.00178	0.00277	CcSEcCtD
Oxymorphone—OPRK1—GPCRs, Class A Rhodopsin-like—CCR6—Crohn's disease	0.00178	0.00592	CbGpPWpGaD
Oxymorphone—OPRK1—GPCR ligand binding—CCR9—Crohn's disease	0.00175	0.00583	CbGpPWpGaD
Oxymorphone—OPRD1—Class A/1 (Rhodopsin-like receptors)—CCR6—Crohn's disease	0.00174	0.00578	CbGpPWpGaD
Oxymorphone—Hypersensitivity—Prednisone—Crohn's disease	0.00166	0.00258	CcSEcCtD
Oxymorphone—OPRM1—IL4-mediated signaling events—JAK2—Crohn's disease	0.00166	0.00552	CbGpPWpGaD
Oxymorphone—OPRD1—GPCR downstream signaling—MLN—Crohn's disease	0.00163	0.00542	CbGpPWpGaD
Oxymorphone—OPRK1—GPCR ligand binding—GPR65—Crohn's disease	0.00163	0.00542	CbGpPWpGaD
Oxymorphone—OPRM1—G alpha (i) signalling events—CCR6—Crohn's disease	0.00162	0.00539	CbGpPWpGaD
Oxymorphone—Asthenia—Prednisone—Crohn's disease	0.00162	0.00251	CcSEcCtD
Oxymorphone—Pruritus—Prednisone—Crohn's disease	0.0016	0.00248	CcSEcCtD
Oxymorphone—OPRK1—GPCRs, Class A Rhodopsin-like—PTGER4—Crohn's disease	0.00156	0.00521	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling by GPCR—ACKR2—Crohn's disease	0.00156	0.00519	CbGpPWpGaD
Oxymorphone—Diarrhoea—Prednisone—Crohn's disease	0.00154	0.0024	CcSEcCtD
Oxymorphone—OPRD1—Class A/1 (Rhodopsin-like receptors)—PTGER4—Crohn's disease	0.00153	0.00509	CbGpPWpGaD
Oxymorphone—OPRK1—Class A/1 (Rhodopsin-like receptors)—CCR6—Crohn's disease	0.00152	0.00507	CbGpPWpGaD
Oxymorphone—OPRM1—GPCRs, Class A Rhodopsin-like—CCR6—Crohn's disease	0.0015	0.005	CbGpPWpGaD
Oxymorphone—Dizziness—Prednisone—Crohn's disease	0.00149	0.00232	CcSEcCtD
Oxymorphone—OPRM1—GPCR ligand binding—CCR9—Crohn's disease	0.00148	0.00493	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling by GPCR—MLN—Crohn's disease	0.00148	0.00492	CbGpPWpGaD
Oxymorphone—Vomiting—Prednisone—Crohn's disease	0.00143	0.00223	CcSEcCtD
Oxymorphone—OPRK1—GPCR downstream signaling—MLN—Crohn's disease	0.00143	0.00475	CbGpPWpGaD
Oxymorphone—Dermatitis—Prednisone—Crohn's disease	0.00142	0.00221	CcSEcCtD
Oxymorphone—Headache—Prednisone—Crohn's disease	0.00141	0.0022	CcSEcCtD
Oxymorphone—OPRM1—GPCR ligand binding—GPR65—Crohn's disease	0.00138	0.00458	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling by GPCR—ACKR2—Crohn's disease	0.00137	0.00455	CbGpPWpGaD
Oxymorphone—OPRK1—Class A/1 (Rhodopsin-like receptors)—PTGER4—Crohn's disease	0.00134	0.00446	CbGpPWpGaD
Oxymorphone—Nausea—Prednisone—Crohn's disease	0.00134	0.00208	CcSEcCtD
Oxymorphone—OPRM1—GPCRs, Class A Rhodopsin-like—PTGER4—Crohn's disease	0.00132	0.0044	CbGpPWpGaD
Oxymorphone—OPRD1—GPCR ligand binding—CCR6—Crohn's disease	0.00132	0.0044	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling by GPCR—MLN—Crohn's disease	0.0013	0.00431	CbGpPWpGaD
Oxymorphone—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCR6—Crohn's disease	0.00129	0.00428	CbGpPWpGaD
Oxymorphone—OPRM1—GPCR downstream signaling—MLN—Crohn's disease	0.00121	0.00402	CbGpPWpGaD
Oxymorphone—OPRM1—TCR Signaling Pathway—CD4—Crohn's disease	0.00117	0.00389	CbGpPWpGaD
Oxymorphone—OPRD1—GPCR ligand binding—PTGER4—Crohn's disease	0.00116	0.00388	CbGpPWpGaD
Oxymorphone—OPRK1—GPCR ligand binding—CCR6—Crohn's disease	0.00116	0.00386	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—ACKR2—Crohn's disease	0.00116	0.00385	CbGpPWpGaD
Oxymorphone—OPRM1—Class A/1 (Rhodopsin-like receptors)—PTGER4—Crohn's disease	0.00113	0.00377	CbGpPWpGaD
Oxymorphone—OPRD1—GPCR downstream signaling—CCR9—Crohn's disease	0.00113	0.00376	CbGpPWpGaD
Oxymorphone—CYP2D6—Metapathway biotransformation—GPX4—Crohn's disease	0.00112	0.00373	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—MLN—Crohn's disease	0.0011	0.00365	CbGpPWpGaD
Oxymorphone—OPRM1—TCR Signaling Pathway—IL1B—Crohn's disease	0.00108	0.00359	CbGpPWpGaD
Oxymorphone—OPRD1—GPCR downstream signaling—GPR65—Crohn's disease	0.00105	0.00349	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling by GPCR—CCR9—Crohn's disease	0.00102	0.00341	CbGpPWpGaD
Oxymorphone—OPRK1—GPCR ligand binding—PTGER4—Crohn's disease	0.00102	0.0034	CbGpPWpGaD
Oxymorphone—OPRK1—GPCR downstream signaling—CCR9—Crohn's disease	0.000989	0.00329	CbGpPWpGaD
Oxymorphone—OPRM1—GPCR ligand binding—CCR6—Crohn's disease	0.00098	0.00326	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling by GPCR—GPR65—Crohn's disease	0.000952	0.00317	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—ACKR2—Crohn's disease	0.000921	0.00307	CbGpPWpGaD
Oxymorphone—OPRK1—GPCR downstream signaling—GPR65—Crohn's disease	0.000919	0.00306	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling by GPCR—CCR9—Crohn's disease	0.000898	0.00299	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—MLN—Crohn's disease	0.000873	0.00291	CbGpPWpGaD
Oxymorphone—OPRM1—GPCR ligand binding—PTGER4—Crohn's disease	0.000863	0.00287	CbGpPWpGaD
Oxymorphone—OPRM1—GPCR downstream signaling—CCR9—Crohn's disease	0.000836	0.00278	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling by GPCR—GPR65—Crohn's disease	0.000835	0.00278	CbGpPWpGaD
Oxymorphone—OPRD1—Peptide ligand-binding receptors—CXCL8—Crohn's disease	0.000834	0.00278	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—ACKR2—Crohn's disease	0.000807	0.00269	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—TAGAP—Crohn's disease	0.000798	0.00266	CbGpPWpGaD
Oxymorphone—OPRM1—GPCR downstream signaling—GPR65—Crohn's disease	0.000777	0.00259	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—MLN—Crohn's disease	0.000765	0.00255	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—CCR9—Crohn's disease	0.000759	0.00253	CbGpPWpGaD
Oxymorphone—OPRD1—GPCR downstream signaling—CCR6—Crohn's disease	0.000747	0.00249	CbGpPWpGaD
Oxymorphone—CYP3A4—Metapathway biotransformation—GPX4—Crohn's disease	0.000732	0.00244	CbGpPWpGaD
Oxymorphone—OPRK1—Peptide ligand-binding receptors—CXCL8—Crohn's disease	0.000731	0.00244	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—GPR65—Crohn's disease	0.000706	0.00235	CbGpPWpGaD
Oxymorphone—OPRD1—G alpha (i) signalling events—CXCL8—Crohn's disease	0.000704	0.00234	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—TAGAP—Crohn's disease	0.0007	0.00233	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—RSPO3—Crohn's disease	0.000698	0.00232	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—ACKR2—Crohn's disease	0.000682	0.00227	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling by GPCR—CCR6—Crohn's disease	0.000678	0.00226	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—SEL1L—Crohn's disease	0.000662	0.0022	CbGpPWpGaD
Oxymorphone—OPRD1—GPCR downstream signaling—PTGER4—Crohn's disease	0.000658	0.00219	CbGpPWpGaD
Oxymorphone—OPRK1—GPCR downstream signaling—CCR6—Crohn's disease	0.000655	0.00218	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—MLN—Crohn's disease	0.000647	0.00215	CbGpPWpGaD
Oxymorphone—OPRM1—TCR Signaling Pathway—IL6—Crohn's disease	0.000631	0.0021	CbGpPWpGaD
Oxymorphone—OPRM1—Peptide ligand-binding receptors—CXCL8—Crohn's disease	0.000618	0.00206	CbGpPWpGaD
Oxymorphone—OPRK1—G alpha (i) signalling events—CXCL8—Crohn's disease	0.000617	0.00205	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—RSPO3—Crohn's disease	0.000612	0.00204	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—CCR9—Crohn's disease	0.000605	0.00201	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling by GPCR—PTGER4—Crohn's disease	0.000597	0.00199	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling by GPCR—CCR6—Crohn's disease	0.000595	0.00198	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—TAGAP—Crohn's disease	0.000592	0.00197	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—SEL1L—Crohn's disease	0.00058	0.00193	CbGpPWpGaD
Oxymorphone—OPRK1—GPCR downstream signaling—PTGER4—Crohn's disease	0.000577	0.00192	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—GPR65—Crohn's disease	0.000562	0.00187	CbGpPWpGaD
Oxymorphone—OPRD1—GPCR downstream signaling—IL3—Crohn's disease	0.00056	0.00187	CbGpPWpGaD
Oxymorphone—OPRD1—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	0.000559	0.00186	CbGpPWpGaD
Oxymorphone—OPRM1—GPCR downstream signaling—CCR6—Crohn's disease	0.000554	0.00184	CbGpPWpGaD
Oxymorphone—OPRD1—GPCR downstream signaling—RASGRP1—Crohn's disease	0.000542	0.0018	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—CCR9—Crohn's disease	0.000531	0.00177	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling by GPCR—PTGER4—Crohn's disease	0.000524	0.00174	CbGpPWpGaD
Oxymorphone—OPRM1—G alpha (i) signalling events—CXCL8—Crohn's disease	0.000521	0.00174	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—RSPO3—Crohn's disease	0.000517	0.00172	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling by GPCR—IL3—Crohn's disease	0.000509	0.00169	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—CCR6—Crohn's disease	0.000503	0.00167	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—GPR65—Crohn's disease	0.000493	0.00164	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling by GPCR—RASGRP1—Crohn's disease	0.000492	0.00164	CbGpPWpGaD
Oxymorphone—OPRK1—GPCR downstream signaling—IL3—Crohn's disease	0.000491	0.00164	CbGpPWpGaD
Oxymorphone—OPRK1—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	0.000491	0.00163	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—SEL1L—Crohn's disease	0.00049	0.00163	CbGpPWpGaD
Oxymorphone—OPRM1—GPCR downstream signaling—PTGER4—Crohn's disease	0.000487	0.00162	CbGpPWpGaD
Oxymorphone—OPRK1—GPCR downstream signaling—RASGRP1—Crohn's disease	0.000475	0.00158	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—CCR9—Crohn's disease	0.000448	0.00149	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling by GPCR—IL3—Crohn's disease	0.000446	0.00149	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—PTGER4—Crohn's disease	0.000443	0.00147	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling by GPCR—RASGRP1—Crohn's disease	0.000431	0.00144	CbGpPWpGaD
Oxymorphone—OPRD1—GPCR ligand binding—CXCL8—Crohn's disease	0.000426	0.00142	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—GPR65—Crohn's disease	0.000417	0.00139	CbGpPWpGaD
Oxymorphone—OPRM1—GPCR downstream signaling—IL3—Crohn's disease	0.000415	0.00138	CbGpPWpGaD
Oxymorphone—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	0.000415	0.00138	CbGpPWpGaD
Oxymorphone—OPRM1—GPCR downstream signaling—RASGRP1—Crohn's disease	0.000402	0.00134	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—CCR6—Crohn's disease	0.000401	0.00133	CbGpPWpGaD
Oxymorphone—OPRD1—GPCR downstream signaling—IL2RA—Crohn's disease	0.000392	0.00131	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—IL3—Crohn's disease	0.000377	0.00126	CbGpPWpGaD
Oxymorphone—OPRK1—GPCR ligand binding—CXCL8—Crohn's disease	0.000374	0.00124	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—RASGRP1—Crohn's disease	0.000365	0.00121	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—RBX1—Crohn's disease	0.000362	0.00121	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling by GPCR—IL2RA—Crohn's disease	0.000356	0.00119	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—PTGER4—Crohn's disease	0.000353	0.00118	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—CCR6—Crohn's disease	0.000351	0.00117	CbGpPWpGaD
Oxymorphone—OPRK1—GPCR downstream signaling—IL2RA—Crohn's disease	0.000344	0.00115	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—UBE2D1—Crohn's disease	0.000318	0.00106	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—RBX1—Crohn's disease	0.000318	0.00106	CbGpPWpGaD
Oxymorphone—OPRM1—GPCR ligand binding—CXCL8—Crohn's disease	0.000316	0.00105	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—PLA2G4F—Crohn's disease	0.000313	0.00104	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling by GPCR—IL2RA—Crohn's disease	0.000313	0.00104	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—PTGER4—Crohn's disease	0.000309	0.00103	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—RIPK2—Crohn's disease	0.000308	0.00103	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—IL3—Crohn's disease	0.000301	0.001	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—CCR6—Crohn's disease	0.000297	0.000989	CbGpPWpGaD
Oxymorphone—OPRM1—GPCR downstream signaling—IL2RA—Crohn's disease	0.000291	0.000969	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—RASGRP1—Crohn's disease	0.000291	0.000968	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—UBE2D1—Crohn's disease	0.000279	0.000928	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—RIPK2—Crohn's disease	0.00027	0.0009	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—RBX1—Crohn's disease	0.000269	0.000895	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—MTMR3—Crohn's disease	0.000266	0.000886	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—IL2RA—Crohn's disease	0.000264	0.00088	CbGpPWpGaD
Oxymorphone—OPRD1—GPCR downstream signaling—JAK2—Crohn's disease	0.000264	0.000878	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—IL3—Crohn's disease	0.000264	0.000878	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—SOCS1—Crohn's disease	0.000263	0.000877	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—PTGER4—Crohn's disease	0.000261	0.000871	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—RASGRP1—Crohn's disease	0.000255	0.000849	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling by GPCR—TYK2—Crohn's disease	0.000251	0.000836	CbGpPWpGaD
Oxymorphone—OPRD1—GPCR downstream signaling—CXCL8—Crohn's disease	0.000241	0.000802	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling by GPCR—JAK2—Crohn's disease	0.00024	0.000798	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—UBE2D1—Crohn's disease	0.000236	0.000784	CbGpPWpGaD
Oxymorphone—OPRK1—GPCR downstream signaling—JAK2—Crohn's disease	0.000231	0.00077	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—SOCS1—Crohn's disease	0.000231	0.000769	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—RIPK2—Crohn's disease	0.000228	0.000761	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—SMAD3—Crohn's disease	0.000227	0.000757	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—IL3—Crohn's disease	0.000223	0.000742	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling by GPCR—TYK2—Crohn's disease	0.00022	0.000733	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling by GPCR—CXCL8—Crohn's disease	0.000219	0.000728	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—RASGRP1—Crohn's disease	0.000215	0.000717	CbGpPWpGaD
Oxymorphone—OPRK1—GPCR downstream signaling—CXCL8—Crohn's disease	0.000211	0.000703	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—IL2RA—Crohn's disease	0.000211	0.000701	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling by GPCR—JAK2—Crohn's disease	0.00021	0.0007	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—FADS1—Crohn's disease	0.000207	0.00069	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—PLA2G4F—Crohn's disease	0.000205	0.000681	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—SMAD3—Crohn's disease	0.000199	0.000664	CbGpPWpGaD
Oxymorphone—OPRM1—GPCR downstream signaling—JAK2—Crohn's disease	0.000195	0.000651	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—SOCS1—Crohn's disease	0.000195	0.00065	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—GPX4—Crohn's disease	0.000194	0.000646	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling by GPCR—CXCL8—Crohn's disease	0.000192	0.000638	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—GCKR—Crohn's disease	0.000187	0.000624	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—TYK2—Crohn's disease	0.000186	0.00062	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—IL2RA—Crohn's disease	0.000185	0.000615	CbGpPWpGaD
Oxymorphone—OPRM1—GPCR downstream signaling—CXCL8—Crohn's disease	0.000178	0.000594	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—JAK2—Crohn's disease	0.000178	0.000591	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—MTMR3—Crohn's disease	0.000174	0.000579	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—SMAD3—Crohn's disease	0.000169	0.000561	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—CXCL8—Crohn's disease	0.000162	0.00054	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—IL2RA—Crohn's disease	0.000156	0.00052	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—TYK2—Crohn's disease	0.000148	0.000494	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—JAK2—Crohn's disease	0.000142	0.000471	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—FADS1—Crohn's disease	0.000135	0.000451	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—TYK2—Crohn's disease	0.00013	0.000433	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—CXCL8—Crohn's disease	0.000129	0.00043	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—GPX4—Crohn's disease	0.000127	0.000422	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—JAK2—Crohn's disease	0.000124	0.000413	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling by GPCR—IL6—Crohn's disease	0.000123	0.000409	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—GCKR—Crohn's disease	0.000123	0.000408	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—CXCL8—Crohn's disease	0.000113	0.000377	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—TYK2—Crohn's disease	0.00011	0.000366	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling by GPCR—IL6—Crohn's disease	0.000108	0.000359	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—JAK2—Crohn's disease	0.000105	0.000349	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—STAT3—Crohn's disease	0.000104	0.000346	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—CXCL8—Crohn's disease	9.57e-05	0.000319	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—STAT3—Crohn's disease	9.11e-05	0.000303	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—IL6—Crohn's disease	9.1e-05	0.000303	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—STAT3—Crohn's disease	7.7e-05	0.000256	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—IL6—Crohn's disease	7.25e-05	0.000242	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—IL6—Crohn's disease	6.36e-05	0.000212	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—ALB—Crohn's disease	5.96e-05	0.000199	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—IL6—Crohn's disease	5.38e-05	0.000179	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—PTGS2—Crohn's disease	5.22e-05	0.000174	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—ALB—Crohn's disease	3.9e-05	0.00013	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—PTGS2—Crohn's disease	3.41e-05	0.000114	CbGpPWpGaD
